Encyclopedia entry
Pen vs vial GLP-1 delivery
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last updated 2026-05-22
UK licensed GLP-1 medications are delivered to patients in two formats: pre-filled multi-dose pens (KwikPens) and single-use pre-filled vial-and-syringe formats. The format affects dose precision, ease of use, packaging waste, and storage logistics. Current UK Mounjaro delivery shifted from vials to KwikPens during 2024 to 2025.
Pre-filled pens
- · KwikPen for Mounjaro: a multi-dose pen with dial-set dosing across the licensed dose range.
- · Wegovy FlexTouch: a weekly disposable single-use pen pre-set to one of the licensed titration steps.
- · Saxenda FlexTouch: a multi-dose pen with dial-set dosing across the licensed dose range.
- · Advantages: ease of use, error reduction, easier travel.
- · Disadvantages: higher unit cost for the manufacturer, more plastic packaging.
Single-use vials
- · Tirzepatide single-use vial format: still available in the US through some compounding sources; not the current UK route.
- · Advantages: cheaper unit cost, theoretical dose flexibility.
- · Disadvantages: requires the patient to draw up the dose accurately each time, increases dose-error risk, more clinical training required.
Current UK position
Eli Lilly transitioned UK Mounjaro supply from vials to KwikPens during 2024 to 2025 to align with the rest of the UK GLP-1 market and reduce dose-error rates in real-world use. Novo Nordisk Wegovy has been pen-only in the UK since launch. Saxenda is multi-dose pen. UK pharmacies dispense whatever format is licensed; vial-format GLP-1 is not a routine UK option.
Pen vs vial at a glance
| Feature | Pre-filled pen | Single-use vial |
|---|---|---|
| Dose control | Dial-set or pre-set to licensed steps; lower error rate | Patient draws up each dose; higher dose-error risk |
| Ease of use | Higher; easier travel and self-administration | Lower; more clinical training required |
| Unit cost and waste | Higher manufacturer unit cost, more plastic packaging | Cheaper unit cost, theoretical dose flexibility |
| UK examples | Mounjaro KwikPen, Wegovy FlexTouch, Saxenda FlexTouch | Tirzepatide vial (US route, some compounding sources) |
| Current UK availability | The routine UK format across the GLP-1 market | Not a routine UK option |
Editorial comparison of delivery formats. Not a recommendation. Your prescriber and pharmacy dispense the licensed format; we publish no administration or dosing instructions.
Frequently asked questions
Does the UK still supply Mounjaro in vials?
No. Eli Lilly transitioned UK Mounjaro supply from vials to KwikPens during 2024 to 2025 to align with the rest of the UK GLP-1 market and reduce dose-error rates. Vial-format GLP-1 is not a routine UK option.
Why are pens preferred over vials in the UK?
Pens dial or pre-set the dose to licensed steps, which reduces dose-error risk and makes self-administration and travel easier. Vials require the patient to draw up each dose accurately, which raises error risk and needs more clinical training.
Which UK GLP-1 medications come as pens?
Mounjaro is supplied as a KwikPen, Wegovy as a FlexTouch single-use weekly pen, and Saxenda as a multi-dose FlexTouch pen. UK pharmacies dispense the licensed format; this page does not advise on administration.
Related: cold chain · compounded vs licensed.